Syros Pharmaceuticals (SYRS)
(Delayed Data from NSDQ)
$5.47 USD
-0.20 (-3.53%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $5.40 -0.07 (-1.28%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.76 | 1.75% |
Earnings Summary
For their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$0.70 per share, beating the Zacks Consensus Estimate of $-0.79 per share. This reflects a positive earnings surprise of 11.39%. Look out for SYRS's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.76 per share, reflecting a year-over-year increase of 43.7%.
Earnings History
Price & Consensus
Zacks News for SYRS
2seventy bio, Inc. (TSVT) Reports Q1 Loss, Tops Revenue Estimates
SYRS: What are Zacks experts saying now?
Zacks Private Portfolio Services